Excellent varicose vein treatment for you and your patients

The ELVes Radial Slim fiber provides the easiest access to the veins.

The laser procedure for the varicose vein treatment of tomorrow

Minimally invasive laser procedures have revolutionized surgery. They are increasingly being implemented to treat varicose veins around the world.
As a global pioneer in laser technique, biolitec® has changed the future of endovenous laser therapy “radially”. With the combination of the first medical 1470 nm diode laser and the patented radial (360°) emission of the ELVeS® Radial® fiber, the ELVeS® Radial® procedure provides an easy-to-use system for a significantly improved treatment outcome.

View Related Products

Why Radial Fibers?

When combined with the 1470 nm laser source, this laser fiber that emits at 360° affords the ideal endovenous thermal ablation. It is therefore, possible to gently and evenly introduce the laser energy into the lumen of the vein and ensure the closure of the vein based on photothermal destruction. Perforation of the vein wall and the associated thermal irritation of the surrounding tissue are prevented, thereby minimizing postoperative pain, ecchymosis, and other side effects.
Why Slim Fiber?

The ELVes Radial Slim fiber provides the easiest access to the veins. It is characterized by a very small outer diameter of only 1.2mm. When using commercially available 16 G cannulas, the fibers can be introduced without the need for expensive insertion instruments. The simple use of several of these standard cannulas makes access much easier - even for highly convoluted or duplicated veins. Also, when treating perforating veins or recurrences, access is greatly facilitated.

"The ELVeS Radial™ procedure minimizes any post-operative inflammatory pain and bruising, due to a 40 times or greater absorption coefficient in water compared to 810 nm ‒ 980 nm lasers targeting hemoglobin. Incompetent veins treated with ELVeS Radial™ showed a 30 ‒ 40 % reduction in vein diameter one day after the procedure as well as highest occlusion rates in a D1, D10, D30, 6 and 12 months follow-up."

Dr. Uldis Maurins
Riga, Latvia